TABLE 5.
Protective efficacy of a single dose of recombinant B. anthracis against anthrax infection in guinea pigs
Vaccinationa | No. survived/no. challenged (%)b | Time to death (days)c |
P value vs:
|
Serological responsef | |
---|---|---|---|---|---|
PBSd | Next entrye | ||||
ΔSterne(pPA102) | 7/17 (41) | 9.8 ± 1.3 | 0.0001 | 0.1534 | 2,111 |
ΔANR(pPA102) | 4/17 (24) | 6.0 ± 0.7 | 0.0001 | 0.3145 | 926 |
ΔSterne(pJB2) | 2/19 (11) | 5.1 ± 0.6 | 0.0001 | 0.0004 | 192 |
ΔSterne(pJB3) | 0/19 (0) | 2.8 ± 0.2 | 0.0002 | 0.6673 | 33 |
ΔANR(pJB3) | 0/19 (0) | 2.8 ± 0.2 | 0.0005 | 0.0005 | 132 |
PBS | 0/20 (0) | 2.0 ± 0.0 | <10 |
Guinea pigs were vaccinated i.m. with a single dose of 109 spores or PBS.
Animals were challenged with 2,000 LD50 of Ames spores i.m. 6 weeks after vaccination.
Harmonic mean time to death ± the standard error of the mean.
P value versus the PBS control of the survival estimate calculated by using the Log Rank test from the Lifetest procedure of the SAS Statistical Software package.
P value versus the subsequent entry in this table [i.e., entry 2, ΔANR(pPA102), versus entry 3, ΔSterne(pJB2)] of the survival estimate calculated by using the Log Rank test from the Lifetest procedure of the SAS Statistical Software package.
Reciprocal geometric mean anti-PA titer of prechallenge sera (determined by enzyme-linked immunosorbent assay).